How do you choose first-line therapy for patients with non-small cell lung cancer and both a driver mutation and high tumor PD-L1 expression?
Speaker Name: Dr.West
Welcome to PrecisCa - Your Trusted Source for Oncology 2nd Opinions.
At PrecisCa, we are dedicated to providing expert second opinions to community Oncologists for their cancer patients to ensure they receive the best possible care. Our videos cover a wide range of topics related to oncology, including in-depth discussions on different types of cancer, complex patient case panel discussions, treatment options, patient stories, and the latest advancements in cancer research. Whether you're looking for something case specific, or simply seeking to expand your knowledge, our goal is to support you on your healthcare journey.
Visit our website: [ Ссылка ] for more detailed information and personalized second opinions.
Stay connected with us:
- Facebook: [ Ссылка ]
- Twitter: [ Ссылка ]
-Instagram: [ Ссылка ]
-LinkedIn: [ Ссылка ]
Don't forget to subscribe to our channel for regular updates and new videos. Hit the bell icon to receive notifications every time we upload. #Oncology #CancerCare #CancerSupport #CancerResearch #Health #Healthcare #CancerTreatment #CancerAwareness #PatientCare #MedicalAdvice #PrecisCa
#LungCancer #LungCancerAwareness #LungCancerSymptoms #LungCancerDiagnosis #LungCancerTreatment #Oncology #CancerResearch #Healthcare #EarlyDetection #CancerSupport #LungCancerStages #RiskFactors #Screening #Prevention #CancerSurvivor #CTScan #Chemotherapy #RadiationTherapy #SmallCellLungCancer #NonSmallCellLungCancer #Smoking #Causes #Immunotherapy #TargetedTherapy #LungHealth #RespiratoryHealth
Thank you for watching and supporting PrecisCa.
